Surgical approach to hysterectomy for benign gynaecological disease

Theodoor E. Nieboer, Neil Johnson, Anne Lethaby, Emma Tavender, Elizabeth Curr, Ray Garry, Sabine Van Voorst, Ben Willem J Mol, Kirsten B. Kluivers

Research output: Contribution to journalReview article

543 Citations (Scopus)

Abstract

Background: The three approaches to hysterectomy for benign disease are abdominal hysterectomy (AH), vaginal hysterectomy (VH), and laparoscopic hysterectomy (LH). Laparoscopic hysterectomy has three further subdivisions depending on the part of the procedure performed laparoscopically. Objectives: To assess the most beneficial and least harmful surgical approach to hysterectomy for women with benign gynaecological conditions. Search strategy: We searched the Cochrane Menstrual Disorders and Subfertility Group Specialised Register of controlled trials (15 August 2008), CENTRAL (The Cochrane Library 2008, Issue 3), MEDLINE (1950 to August 2008), EMBASE (1980 to August 2008), Biological Abstracts (1969 to August 2008), the National Research Register, and relevant citation lists. Selection criteria: Only randomised controlled trials comparing one surgical approach to hysterectomy with another were included. Data collection and analysis: Independent selection of trials and data extraction were employed following Cochrane guidelines. Main results: There were 34 included studies with 4495 women. The benefits of VH versus AH were speedier return to normal activities (mean difference (MD) 9.5 days), fewer febrile episodes or unspecified infections (odds ratio (OR) 0.42), and shorter duration of hospital stay (MD 1.1 days). The benefits of LH versus AH were speedier return to normal activities (MD 13.6 days), lower intraoperative blood loss (MD 45 cc), a smaller drop in haemoglobin (MD 0.55 g/dl), shorter hospital stay (MD 2.0 days), and fewer wound or abdominal wall infections (OR 0.31) at the cost of more urinary tract (bladder or ureter) injuries (OR 2.41) and longer operation time (MD 20.3 minutes). The benefits of LAVH versus TLH were fewer febrile episodes or unspecified infection (OR 3.77) and shorter operation time (MD 25.3 minutes). There was no evidence of benefits of LH versus VH and the operation time (MD 39.3 minutes) as well as substantial bleeding (OR 2.76) were increased in LH. For some important outcomes, the analyses were underpowered to detect important differences or they were simply not reported in trials. Data were absent for many important long-term outcome measures. Authors' conclusions: Because of equal or significantly better outcomes on all parameters, VH should be performed in preference to AH where possible. Where VH is not possible, LH may avoid the need for AH however the length of the surgery increases as the extent of the surgery performed laparoscopically increases. The surgical approach to hysterectomy should be decided by the woman in discussion with her surgeon in light of the relative benefits and hazards.

LanguageEnglish
Article numberCD003677
JournalCochrane Database of Systematic Reviews
Issue number3
DOIs
Publication statusPublished - 15 Sep 2009

Keywords

  • Female
  • Genital diseases, female [*surgery]
  • Humans
  • Hysterectomy [adverse effects; *methods]
  • Hysterectomy, vaginal [adverse effects; methods]
  • Laparoscopy [adverse effects; *methods]
  • Randomized controlled trials as topic

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Nieboer, T. E., Johnson, N., Lethaby, A., Tavender, E., Curr, E., Garry, R., ... Kluivers, K. B. (2009). Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database of Systematic Reviews, (3), [CD003677]. https://doi.org/10.1002/14651858.CD003677.pub4
Nieboer, Theodoor E. ; Johnson, Neil ; Lethaby, Anne ; Tavender, Emma ; Curr, Elizabeth ; Garry, Ray ; Van Voorst, Sabine ; Mol, Ben Willem J ; Kluivers, Kirsten B. / Surgical approach to hysterectomy for benign gynaecological disease. In: Cochrane Database of Systematic Reviews. 2009 ; No. 3.
@article{702a735b7cf3433ab831ab90a42d35cc,
title = "Surgical approach to hysterectomy for benign gynaecological disease",
abstract = "Background: The three approaches to hysterectomy for benign disease are abdominal hysterectomy (AH), vaginal hysterectomy (VH), and laparoscopic hysterectomy (LH). Laparoscopic hysterectomy has three further subdivisions depending on the part of the procedure performed laparoscopically. Objectives: To assess the most beneficial and least harmful surgical approach to hysterectomy for women with benign gynaecological conditions. Search strategy: We searched the Cochrane Menstrual Disorders and Subfertility Group Specialised Register of controlled trials (15 August 2008), CENTRAL (The Cochrane Library 2008, Issue 3), MEDLINE (1950 to August 2008), EMBASE (1980 to August 2008), Biological Abstracts (1969 to August 2008), the National Research Register, and relevant citation lists. Selection criteria: Only randomised controlled trials comparing one surgical approach to hysterectomy with another were included. Data collection and analysis: Independent selection of trials and data extraction were employed following Cochrane guidelines. Main results: There were 34 included studies with 4495 women. The benefits of VH versus AH were speedier return to normal activities (mean difference (MD) 9.5 days), fewer febrile episodes or unspecified infections (odds ratio (OR) 0.42), and shorter duration of hospital stay (MD 1.1 days). The benefits of LH versus AH were speedier return to normal activities (MD 13.6 days), lower intraoperative blood loss (MD 45 cc), a smaller drop in haemoglobin (MD 0.55 g/dl), shorter hospital stay (MD 2.0 days), and fewer wound or abdominal wall infections (OR 0.31) at the cost of more urinary tract (bladder or ureter) injuries (OR 2.41) and longer operation time (MD 20.3 minutes). The benefits of LAVH versus TLH were fewer febrile episodes or unspecified infection (OR 3.77) and shorter operation time (MD 25.3 minutes). There was no evidence of benefits of LH versus VH and the operation time (MD 39.3 minutes) as well as substantial bleeding (OR 2.76) were increased in LH. For some important outcomes, the analyses were underpowered to detect important differences or they were simply not reported in trials. Data were absent for many important long-term outcome measures. Authors' conclusions: Because of equal or significantly better outcomes on all parameters, VH should be performed in preference to AH where possible. Where VH is not possible, LH may avoid the need for AH however the length of the surgery increases as the extent of the surgery performed laparoscopically increases. The surgical approach to hysterectomy should be decided by the woman in discussion with her surgeon in light of the relative benefits and hazards.",
keywords = "Female, Genital diseases, female [*surgery], Humans, Hysterectomy [adverse effects; *methods], Hysterectomy, vaginal [adverse effects; methods], Laparoscopy [adverse effects; *methods], Randomized controlled trials as topic",
author = "Nieboer, {Theodoor E.} and Neil Johnson and Anne Lethaby and Emma Tavender and Elizabeth Curr and Ray Garry and {Van Voorst}, Sabine and Mol, {Ben Willem J} and Kluivers, {Kirsten B.}",
year = "2009",
month = "9",
day = "15",
doi = "10.1002/14651858.CD003677.pub4",
language = "English",
journal = "The Cochrane database of systematic reviews",
issn = "1469-493X",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

Nieboer, TE, Johnson, N, Lethaby, A, Tavender, E, Curr, E, Garry, R, Van Voorst, S, Mol, BWJ & Kluivers, KB 2009, 'Surgical approach to hysterectomy for benign gynaecological disease', Cochrane Database of Systematic Reviews, no. 3, CD003677. https://doi.org/10.1002/14651858.CD003677.pub4

Surgical approach to hysterectomy for benign gynaecological disease. / Nieboer, Theodoor E.; Johnson, Neil; Lethaby, Anne; Tavender, Emma; Curr, Elizabeth; Garry, Ray; Van Voorst, Sabine; Mol, Ben Willem J; Kluivers, Kirsten B.

In: Cochrane Database of Systematic Reviews, No. 3, CD003677, 15.09.2009.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Surgical approach to hysterectomy for benign gynaecological disease

AU - Nieboer, Theodoor E.

AU - Johnson, Neil

AU - Lethaby, Anne

AU - Tavender, Emma

AU - Curr, Elizabeth

AU - Garry, Ray

AU - Van Voorst, Sabine

AU - Mol, Ben Willem J

AU - Kluivers, Kirsten B.

PY - 2009/9/15

Y1 - 2009/9/15

N2 - Background: The three approaches to hysterectomy for benign disease are abdominal hysterectomy (AH), vaginal hysterectomy (VH), and laparoscopic hysterectomy (LH). Laparoscopic hysterectomy has three further subdivisions depending on the part of the procedure performed laparoscopically. Objectives: To assess the most beneficial and least harmful surgical approach to hysterectomy for women with benign gynaecological conditions. Search strategy: We searched the Cochrane Menstrual Disorders and Subfertility Group Specialised Register of controlled trials (15 August 2008), CENTRAL (The Cochrane Library 2008, Issue 3), MEDLINE (1950 to August 2008), EMBASE (1980 to August 2008), Biological Abstracts (1969 to August 2008), the National Research Register, and relevant citation lists. Selection criteria: Only randomised controlled trials comparing one surgical approach to hysterectomy with another were included. Data collection and analysis: Independent selection of trials and data extraction were employed following Cochrane guidelines. Main results: There were 34 included studies with 4495 women. The benefits of VH versus AH were speedier return to normal activities (mean difference (MD) 9.5 days), fewer febrile episodes or unspecified infections (odds ratio (OR) 0.42), and shorter duration of hospital stay (MD 1.1 days). The benefits of LH versus AH were speedier return to normal activities (MD 13.6 days), lower intraoperative blood loss (MD 45 cc), a smaller drop in haemoglobin (MD 0.55 g/dl), shorter hospital stay (MD 2.0 days), and fewer wound or abdominal wall infections (OR 0.31) at the cost of more urinary tract (bladder or ureter) injuries (OR 2.41) and longer operation time (MD 20.3 minutes). The benefits of LAVH versus TLH were fewer febrile episodes or unspecified infection (OR 3.77) and shorter operation time (MD 25.3 minutes). There was no evidence of benefits of LH versus VH and the operation time (MD 39.3 minutes) as well as substantial bleeding (OR 2.76) were increased in LH. For some important outcomes, the analyses were underpowered to detect important differences or they were simply not reported in trials. Data were absent for many important long-term outcome measures. Authors' conclusions: Because of equal or significantly better outcomes on all parameters, VH should be performed in preference to AH where possible. Where VH is not possible, LH may avoid the need for AH however the length of the surgery increases as the extent of the surgery performed laparoscopically increases. The surgical approach to hysterectomy should be decided by the woman in discussion with her surgeon in light of the relative benefits and hazards.

AB - Background: The three approaches to hysterectomy for benign disease are abdominal hysterectomy (AH), vaginal hysterectomy (VH), and laparoscopic hysterectomy (LH). Laparoscopic hysterectomy has three further subdivisions depending on the part of the procedure performed laparoscopically. Objectives: To assess the most beneficial and least harmful surgical approach to hysterectomy for women with benign gynaecological conditions. Search strategy: We searched the Cochrane Menstrual Disorders and Subfertility Group Specialised Register of controlled trials (15 August 2008), CENTRAL (The Cochrane Library 2008, Issue 3), MEDLINE (1950 to August 2008), EMBASE (1980 to August 2008), Biological Abstracts (1969 to August 2008), the National Research Register, and relevant citation lists. Selection criteria: Only randomised controlled trials comparing one surgical approach to hysterectomy with another were included. Data collection and analysis: Independent selection of trials and data extraction were employed following Cochrane guidelines. Main results: There were 34 included studies with 4495 women. The benefits of VH versus AH were speedier return to normal activities (mean difference (MD) 9.5 days), fewer febrile episodes or unspecified infections (odds ratio (OR) 0.42), and shorter duration of hospital stay (MD 1.1 days). The benefits of LH versus AH were speedier return to normal activities (MD 13.6 days), lower intraoperative blood loss (MD 45 cc), a smaller drop in haemoglobin (MD 0.55 g/dl), shorter hospital stay (MD 2.0 days), and fewer wound or abdominal wall infections (OR 0.31) at the cost of more urinary tract (bladder or ureter) injuries (OR 2.41) and longer operation time (MD 20.3 minutes). The benefits of LAVH versus TLH were fewer febrile episodes or unspecified infection (OR 3.77) and shorter operation time (MD 25.3 minutes). There was no evidence of benefits of LH versus VH and the operation time (MD 39.3 minutes) as well as substantial bleeding (OR 2.76) were increased in LH. For some important outcomes, the analyses were underpowered to detect important differences or they were simply not reported in trials. Data were absent for many important long-term outcome measures. Authors' conclusions: Because of equal or significantly better outcomes on all parameters, VH should be performed in preference to AH where possible. Where VH is not possible, LH may avoid the need for AH however the length of the surgery increases as the extent of the surgery performed laparoscopically increases. The surgical approach to hysterectomy should be decided by the woman in discussion with her surgeon in light of the relative benefits and hazards.

KW - Female

KW - Genital diseases, female [surgery]

KW - Humans

KW - Hysterectomy [adverse effects; methods]

KW - Hysterectomy, vaginal [adverse effects; methods]

KW - Laparoscopy [adverse effects; methods]

KW - Randomized controlled trials as topic

UR - http://www.scopus.com/inward/record.url?scp=70049113460&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD003677.pub4

DO - 10.1002/14651858.CD003677.pub4

M3 - Review article

JO - The Cochrane database of systematic reviews

T2 - The Cochrane database of systematic reviews

JF - The Cochrane database of systematic reviews

SN - 1469-493X

IS - 3

M1 - CD003677

ER -